An interesting study looking at using a deep learning model to evaluate ECGs in the emergency room to determine if patients need coronary revascularization as existing methods can sometimes be inconclusive.
academic.oup.com/eurheartj/ad...
@thornsberryjd.bsky.social
π DNP π₯Ό Nurse Practitioner π« Hearts π₯ APP Fellowship Director π Educator π ATL π³οΈβπ LGBTQ+ βΊοΈ Camper #ACC #ACCCVT #CCKE #ACCPRIDE #AANP #NPsLead #CardioSky #MedSky DNP, AGACNP-BC, ANP-BC, CCK, AACC
An interesting study looking at using a deep learning model to evaluate ECGs in the emergency room to determine if patients need coronary revascularization as existing methods can sometimes be inconclusive.
academic.oup.com/eurheartj/ad...
Tomorrow is your last chance to visit this BP measurement learning station at #ACC25!
Avoiding common pitfalls is key to accurate careβdonβt miss it in the Personalized Skills Center.
learn.acc.org/Page/LEARNHTN
#ACCCVT #CardioSky #WellstarCVteam
@accintouch.bsky.social @jaccjournals.bsky.social
ALPACA: The novel extended-duration small interfering RNA lepodisiran reduced mean serum concentrations of Lp(a) from 60 to 180 days after being administered subcutaneously. #ACC25
Learn more about the study β‘οΈ bit.ly/3Y1DkU7
#CardioSky #MedSky
Dr. Victor Dzau presenting his keynote speech, Science, Medicine, and Society: A Brave New World, during the 2025 Eugene Braunwald Keynote happening now! πRoom S100b
#ACC25 #CardioSky
FRESH-UP Trial #ACC25 #medsky
RCT comparing liberal vs restricted fluid intake (β€1500 ml/d) in 504 pts with stable chronic HF
πNo difference in status health quantified by Kansas City Cardiomyopathy Questionnaire at 3 mths
π More thirst distress with restriction
www.nature.com/articles/s41...
Dr. Victor Dzau:
How do we improve #cvd with rising #obesity?
β
Start with 1Β° and 2Β° #cvprev
β
Primordial prevention
@accintouch.bsky.social #acc25
Dr. Victor Dzau:
Future of #CVD care is going to be evolving rapidly over the next century:
β€οΈ Emphasis on prevention
β€οΈ Equitable access and affordable
β€οΈ Mission-based innovation
β€οΈ Develop national priorities
Need governance to oversee innovation, ensure ethics
#acc25
@accintouch.bsky.social
A multidisciplinary approachβfrom cardiology to nursing to pharmacyβshows whatβs possible when we work together.
The result? A jump in SGLT2i prescribing rates and more holistic post-AMI care!
#ACC25 #CardioSky #WellstarCVteam #ACCCVT
@accintouch.bsky.social @jaccjournals.bsky.social
Wellstar team-based care in action at #ACC25!
This poster showcases a coordinated strategy to improve SGLT2i use post-AMIβdriving better prescribing, education, and follow-up for patients.
#ACCCVT #CardioSky #WellstarCVteam
@accintouch.bsky.social @jaccjournals.bsky.social
These findings will reshape how care teams educate and manage patients with HFβallowing us to shift focus from fluid limits to the underlying drivers of decompensation that truly impact outcomes.
@accintouch.bsky.social @jaccjournals.bsky.social
#ACC25 #WellstarCVteam #ACCCVT
FRESH-UP at #ACC25: No benefit to fluid restriction in HF. No harm with liberal intake. Improved QOL with more fluid freedom.
Supports what we have long suspectedβand may help shift the standard of care moving forward.
#CardioSky #WellstarCVteam
@accintouch.bsky.social @jaccjournals.bsky.social
#ACC25 #LGBTQ work group represents at the Health #Equity Hub!
Dr Deb and Dr Coylewright - So proud of the work youβre both doing!
@thornsberryjd.bsky.social
@brototod.bsky.social
Join us for this exciting session on management of CIEDs in complex patients -
#ACC25 #CIED #cardiopalli #SDM
@accintouch.bsky.social @thornsberryjd.bsky.social
EquiOx at #ACC25 confirms it: pulse oximeters donβt perform equally across skin tonesβespecially critically ill patients
Wellstarβs, Dr. Paul Douglass shared insight on the need for equity in device validation
#ACCCVT #CardioSky #WellstarCVteam
@accintouch.bsky.social @jaccjournals.bsky.social
MIGHTy-Heart took on gaps in HF care transitions.
β΄οΈ 2,003 enrolled β MIH vs. TOCC
β΄οΈ No difference in 30-day outcomes
β΄οΈ Younger patients & women saw more benefit.
Impressive representation: 52% women, 47% Black
#ACC25 #CardioSky #WellstarCVteam
@accintouch.bsky.social @jaccjournals.bsky.social
π₯Hot off the press:
Highlights from day 1 at #ACC25 #CardioSky
π WARRIOR
π STRIDE
π API-CAT
π SOUL
π RIVAWAR
π & more in the link
www.healio.com/news/cardiol...
Among persons with type 2 diabetes and atherosclerotic cardiovascular disease, chronic kidney disease, or both, oral semaglutide was associated with a significantly lower risk of major adverse cardiovascular events than placebo #MedSky #CardioSky #NephSky
www.nejm.org/doi/full/10....
More from day 1 #ACC25 β¦
π WARRIOR = the largest study of women with suspected ischemia with nonobstructive coronary disease
π Intensive medical therapy did not prevent π« events for women with INOCA
π βThis trial should not be considered a negative trialβ
www.healio.com/news/cardiol...
You folks lead with compassion! Such important work!
29.03.2025 23:30 β π 2 π 0 π¬ 1 π 0#ACC25 #Palliative Workgroup Huddle!
So much creativity and compassion - and WORK - in the this group!
#ACCGeriatric #ACCFIT #ACCCVT
@accintouch.bsky.social @shummelmd.bsky.social @thornsberryjd.bsky.social
Join us for a fun #CardioObstetrics session at #ACC25 #CardioSky
π
Sun, Mar 30
β° 10AM
@accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social @abraguo.bsky.social @garimasharmamd.bsky.social @drmarthagulati.bsky.social @erinmichos.bsky.social @thornsberryjd.bsky.social
Join us now for #ACC25 #CardioObstetrics Meet-Up
@accintouch.bsky.social @mdharringtonc.bsky.social @drklindley.bsky.social
Today at 4:30PM
Donβt miss #ACC25 #CardioObstetrics Meet-Up
π Mark your calendars for Monday at #ACC25!
Wellstar MCG presents a high-stakes case: RotaWire entrapment, fracture, and retrievalβtitled βWhen It Rains It Pours.β βοΈπ
You wonβt want to miss this one!
#WellstarCVteam #CardioSky
@accintouch.bsky.social @jaccjournals.bsky.social
An oral formulation of semaglutide lowered the risk major adverse cardiovascular events by 14% in four years, with no change in safety profile compared to placebo, according to the SOUL study. #ACC25
Read the journal scan to learn more: bit.ly/3QTpizK
#CardioSky #MedSky
DAPA-TAVI: The #SGLT2 inhibitor dapagliflozin was superior to standard care alone in decreasing rates of all-cause mortality or worsening #HeartFailure in older adults w/ #vhdAS undergoing TAVI, resulting in a 28% relative risk βοΈ. #ACC25
More: bit.ly/4cfLNsy
#cvSurg #CardioSky #MedSky
In SOUL, 2596/9650 (26.9%) participants were receiving SGLT2i at baseline (largest CVOT of combined GLP-1/SGLT2 to date)
The effect of oral semaglutide on cardiovascular outcomes was consistent, regardless of SGLT2i use
#ACC25
www.ahajournals.org/doi/abs/10.1...
I love this!
29.03.2025 21:26 β π 1 π 0 π¬ 0 π 0#equity in heart care.
Yes. β€οΈ
#ACC25 #ACCCVT